Using this model, CLL cells treated with CXCL12 underwent cytoskeletal reorganization measured by F-actin polymerization assay and chemotactic changes that were measured using a transwell migration assay. Here, CXCL12 is linked to B-cell chronic lymphocytic leukemia.